rac1 protein (MedChemExpress)
Structured Review

Rac1 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rac1+protein/pmc12987937-445-0-2?v=MedChemExpress
Average 94 stars, based on 4 article reviews
Images
1) Product Images from "Novel copper-ion coordinated andrographolide-loaded hydrogel activates Rac1/JNK1 axis for enhancing diabetic wound healing"
Article Title: Novel copper-ion coordinated andrographolide-loaded hydrogel activates Rac1/JNK1 axis for enhancing diabetic wound healing
Journal: NPJ Regenerative Medicine
doi: 10.1038/s41536-026-00457-y
Figure Legend Snippet: A Venny plots of Andro target genes vs DWs causative genes. B PPI network highlighting key signaling proteins modulated by Andro treatment. Nodes represent individual proteins (colored by pathway/function; see legend); edges represent validated interactions. Major pathway clusters are annotated (e.g., JNK1/MAPK, Rac1/cell migration). C GO functional enrichment analysis of intersecting targets, showing significantly enriched biological processes (e.g., inflammatory response, cell migration, angiogenesis) ranked by gene count or significance. D KEGG pathway enrichment analysis ranked by gene count and significance. E Top 20 KEGG pathway enrichment analysis (sorted by enrichment score). F Representative docking pose of Andro within the proteins binding pocket, showing key noncovalent interactions.
Techniques Used: Migration, Functional Assay, Binding Assay
Figure Legend Snippet: A RMSD of complex, protein, and Ligand, reflecting structural deviation and conformational stability over time. B Rg of the complex, indicating overall compactness and structural tightness. C Rac1 and Andro binding site distance, monitoring binding stability and positional consistency. D FEL showing a single dominant basin, indicating conformational stability without large-scale reorganization. E Buried area between Andro and Rac1, representing the extent of buried surface and interaction strength. F Simulated conformational superposition, illustrating structural flexibility and binding site variations. G Modeling trajectory change, displaying dynamic shifts in binding site and molecular orientation. H PCA and protein structure, highlighting dominant motion modes and conformational flexibility. I Andro and Rac1 binding energies VDW and ELE, showing contributions from van der Waals and electrostatic interactions. J Hydrogen bond number, reflecting the stability and strength of polar interactions. K Hydrogen bond frequency between Andro and Rac1, indicating persistence and key residues involved in H-bond formation.
Techniques Used: Binding Assay
Figure Legend Snippet: A , B Representative western blots ( A ) and quantification ( B ) of Rac1, JNK1, Jun, and Fos protein levels in wound tissues at day 3 for each treatment group. C Relative mRNA expression levels of Rac1 , Jnk1 , Jun , and Fos in day-3 DW tissues. D SPR analysis confirming direct binding of Andro to Rac1 with a dissociation constant (KD) of 3.82 µM. E Relative mRNA expression levels of Rac1 , Jnk1 , Jun , and Fos in day-7 wound tissues. F , G Representative western blots ( F ) and quantification ( G ) of Rac1, JNK1, Jun, and Fos protein levels in day-7 wound tissues. The bar charts present mean ± SD ( n = 3 per group). * P < 0.05, ** P < 0.01, *** P < 0.001, vs Control group, # P < 0.05, ## P < 0.01, ### P < 0.001, vs Matrix group. H Schematic model summarizing the proposed mechanism by which ASFH-delivered Andro treats DWs. Andro directly binds Rac1, activates the Rac1/JNK1/Jun/Fos signaling axis, promotes M1-to-M2 macrophage polarization, modulates cytokine profiles, enhances angiogenesis and collagen remodeling, and collectively accelerates wound closure.
Techniques Used: Western Blot, Expressing, Binding Assay, Control

![(A and B) Glutathione S-transferase (GST) pull-down from P5 wild-type (WT) mouse sciatic nerve lysate, comparing <t>GST-Rac1-GDP</t> versus GST-Rac1-GTP (A) Volcano plot showing the Welch difference (log2 fold change) of Rac1 interactors. Proteins in red, such as STRN3 and several well-established Rac1 interactors, are significantly (false discovery rate [FDR] = 0.05) enriched in the active Rac1-GTP fraction compared to the inactive Rac1-GDP fraction. MOB4 was found to be enriched in the Rac1-GTP fraction in a separate biological replicate (data not shown). (B) GST-Rac1-GDP/GTP pull-down of P5 WT sciatic nerve lysate was repeated and analyzed by western blot (WB). STRN3 was observed to elute with the active Rac1-GTP fraction but not the inactive Rac1-GDP fraction. (C) Immunoprecipitation of Rac1 from SC lysates. STRN3 was found to interact with Rac1 in SCs. n = 5 individual coIPs per targeting antibody (anti-Rac1 or IgG isotype control). Unpaired two-tailed t test ( t = 3.730, df = 8, p = 0.0058). Error bars indicate SEM. ** p < 0.01.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5956/pmc12035956/pmc12035956__nihms-2069120-f0002.jpg)

